Korean Circ J.  2017 Jul;47(4):440-441. 10.4070/kcj.2017.0139.

The J Curve Phenomenon is Still Valid in the Era of Primary Revascularization

• Lee HY

• KMID: 2392878
• DOI: http://doi.org/10.4070/kcj.2017.0139

Abstract

No abstract available.

Reference

1. Shin J, Park JB, Kim KI, et al. 2013 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology and diagnosis of hypertension. Clin Hypertens. 2015; 21:1.

2. Lee SH, Kim JH, Jeong MH, et al. Clinical characteristics and outcomes of acute ST-segment elevation myocardial infarction in younger Korean adults. Korean Circ J. 2015; 45:275–284.

3. Shin J, Park JB, Kim KI, et al. 2013 Korean Society of Hypertension guidelines for the management of hypertension: part III-hypertension in special situations. Clin Hypertens. 2015; 21:3.

4. Rosendorff C, Black HR, Cannon CP, et al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation. 2007; 115:2761–2788.

5. SPRINT Research Group. Wright JT Jr, Williamson JD, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015; 373:2103–2116.

6. Lonn EM, Bosch J, Lopez-Jaramillo P, et al. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med. 2016; 374:2009–2020.

7. ACCORD Study Group. Cushman WC, Evans GW, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010; 362:1575–1585.

8. Rosendorff C, Lackland DT, Allison M, et al. Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. Hypertension. 2015; 65:1372–1407.

9. Bangalore S, Kumar S, Volodarskiy A, Messerli FH. Blood pressure targets in patients with coronary artery disease: observations from traditional and Bayesian random effects meta-analysis of randomised trials. Heart. 2013; 99:601–613.

10. Moon SH, Moon JC, Heo DH, et al. Increased pulse wave velocity and augmentation index after isometric handgrip exercise in patients with coronary artery disease. Clin Hypertens. 2015; 21:5.

11. Messerli FH, Mancia G, Conti CR, et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med. 2006; 144:884–893.

12. Lu W. Could intensive anti-hypertensive therapy produce the “J-curve effect” in patients with coronary artery disease and hypertension after revascularization? Eur Rev Med Pharmacol Sci. 2016; 20:1350–1355.

13. Park H, Hong YJ, Cho JY, et al. Blood Pressure Targets and Clinical Outcomes in Patients with Acute Myocardial Infarction. Korean Circ J. 2017; 47:446–454.

14. Youn JC, Han S, Ryu KH. Toward a new heart failure registry in Korea. Korean Circ J. 2017; 47:316–317.

15. Sattar N, Preiss D. Reverse causality in cardiovascular epidemiological research: more common than imagined? Circulation. 2017; 135:2369–2372.

16. Lee SE, Lee HY, Cho HJ, et al. Clinical characteristics and outcome of acute heart failure in Korea: results from the Korean acute heart failure registry (KorAHF). Korean Circ J. 2017; 47:341–353.